2023
Minshall M, Emden M, McLin R, Kemp P, Pontenani F, Cardosi L, Sacks N . The cost of non-cystic fibrosis bronchiectasis (NCFB) in patients with commercial insurance or Medicare coverage in the US. Poster presentation, ISPOR, April 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Eichler F, Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr P , Sawyer E, Stephen C. The economic impact of adrenomyeloneuropathy (AMN) on direct medical costs in commercially insured US adults: A retrospective study. Poster presentation, ISPOR 27th International Meeting, Boston, MA, April 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Bonkowsky J, Healey B, Sacks NC , McLin R, Cyr P , Sawyer E, Stephen C. Hospitalizations, clinical characteristics and mortality in adults with adrenomyeloneuropathy (AMN): A retrospective study. Poster presentation, ISPOR 27th International Meeting, Boston, MA, April 2023.
Topics: Health Economics and Outcomes Research (HEOR)
Suh M , Reichert H , Movva N , Fisher K, Wood CT, Wolf Z, et al. Pilot surveillance of infant lower respiratory tract infections and respiratory syncytial virus in the United States during the COVID pandemic. Poster 95, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.
View Abstract
Topics: Epidemiology
Pastula S , Suh M , Jiang X , Reichert H , Movva N , Fryzek J, Simões EAF. Respiratory syncytial virus (RSV) and bronchiolitis epidemiology among the United States infant Medicaid populations in seven states. Poster 191, International Society for Pharmacoepidemiology (ICPE) annual meeting, Halifax, Nova Scotia, August 2023.
View Abstract
Topics: Epidemiology
Pang F, Dean R, Jensen I , Bean K, Fields C, Miller B. 2023. The cost-effectiveness of OTL-200 for the treatment of metachromatic leukodystrophy (MLD) in the US. Mol Gene Metab 138(2):107258; doi: 10.1016/j.ymgme.2022.107258 .
Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
2022
Klosterbuer A, Cekola P, Neutel JM, Jiang X , Cohen SS, Torres KA. Diabetes specific ONS led to a blunted postprandial glucose response and a 26% reduction in peak blood glucose levels compared to a standard ONS. Presented at FNCE 2022 Food & Nutrition Conference & Expo, Orlando, FL, October 2022.
Topics: diabetes
Pang F, Dean R, Jensen I , Tehard B, Roze S, Olaye A, et al. The cost-effectiveness of atidarsagene autotemcel for the treatment of metachromatic leukodystrophy (MLD) in France. Abstract EE24 , ISPOR 2022.
View Abstract
Topics: Health Economics and Outcomes Research (HEOR) , Metachromatic leukodystrophy (MLD)
Habib A, Sacks NC , Cool C, Durgapal S, Hughes T, Hernandez J, Phillips G. Trends in hospital admissions and readmissions for patients with MG from U.S. national research databases. Poster presentation, American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) annual meeting, September 2022.
Topics: Health Economics and Outcomes Research (HEOR)
Sacks NC . Healthcare resource utilization in non-cystic fibrosis bronchiectasis (NCFB) patients with commercial insurance coverage in the US. Poster presentation, International Society for Pharmacoeconomics and Outcomes Research (ISPOR)Europe, November 2022.
A Division of